Year |
Citation |
Score |
2014 |
Patwardhan CA, Peterson LB, Blagg B, Chadli A. Abstract 3197: Gedunin inactivates the co-chaperone p23 causing cancer cell death by apoptosis Cancer Research. 74: 3197-3197. DOI: 10.1158/1538-7445.Am2014-3197 |
0.652 |
|
2013 |
Patwardhan CA, Fauq A, Peterson LB, Miller C, Blagg BS, Chadli A. Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. The Journal of Biological Chemistry. 288: 7313-25. PMID 23355466 DOI: 10.1074/Jbc.M112.427328 |
0.665 |
|
2013 |
Ghosh S, Peterson LB, Vielhauer G, Blagg BSJ. Abstract A16: Role of Hsp90alpha-1, a splice variant of Hsp90alpha, in cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-A16 |
0.478 |
|
2012 |
Zhao H, Yan B, Peterson LB, Blagg BS. 3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibition. Acs Medicinal Chemistry Letters. 3: 327-331. PMID 23316269 DOI: 10.1021/Ml300018E |
0.7 |
|
2012 |
Kusuma BR, Zhang L, Sundstrom T, Peterson LB, Dobrowsky RT, Blagg BS. Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity. Journal of Medicinal Chemistry. 55: 5797-812. PMID 22702513 DOI: 10.1021/Jm300544C |
0.609 |
|
2012 |
Duerfeldt AS, Peterson LB, Maynard JC, Ng CL, Eletto D, Ostrovsky O, Shinogle HE, Moore DS, Argon Y, Nicchitta CV, Blagg BS. Development of a Grp94 inhibitor. Journal of the American Chemical Society. 134: 9796-804. PMID 22642269 DOI: 10.1021/Ja303477G |
0.701 |
|
2012 |
Peterson LB, Eskew JD, Vielhauer GA, Blagg BS. The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking. Molecular Pharmaceutics. 9: 1841-6. PMID 22554505 DOI: 10.1021/Mp300138N |
0.68 |
|
2011 |
Kusuma BR, Peterson LB, Zhao H, Vielhauer G, Holzbeierlein J, Blagg BS. Targeting the heat shock protein 90 dimer with dimeric inhibitors. Journal of Medicinal Chemistry. 54: 6234-53. PMID 21861487 DOI: 10.1021/Jm200553W |
0.616 |
|
2011 |
Matts RL, Dixit A, Peterson LB, Sun L, Voruganti S, Kalyanaraman P, Hartson SD, Verkhivker GM, Blagg BS. Elucidation of the Hsp90 C-terminal inhibitor binding site. Acs Chemical Biology. 6: 800-7. PMID 21548602 DOI: 10.1021/Cb200052X |
0.576 |
|
2011 |
Davenport J, Manjarrez JR, Peterson L, Krumm B, Blagg BS, Matts RL. Gambogic acid, a natural product inhibitor of Hsp90. Journal of Natural Products. 74: 1085-92. PMID 21486005 DOI: 10.1021/Np200029Q |
0.678 |
|
2010 |
Peterson LB, Blagg BS. Click chemistry to probe Hsp90: Synthesis and evaluation of a series of triazole-containing novobiocin analogues. Bioorganic & Medicinal Chemistry Letters. 20: 3957-60. PMID 20570149 DOI: 10.1016/J.Bmcl.2010.04.140 |
0.658 |
|
2010 |
Waldron RT, Peterson LB, Blagg B, Rozengurt E. M1705 Curcumin and Curcumin Analogues Inhibit Mitogenic Signaling in Normal Intestinal Epithelial Cells Gastroenterology. 138: S-402. DOI: 10.1016/S0016-5085(10)61848-3 |
0.511 |
|
2009 |
Peterson LB, Blagg BS. To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Medicinal Chemistry. 1: 267-83. PMID 20161407 DOI: 10.4155/Fmc.09.17 |
0.658 |
|
2009 |
Amolins MW, Peterson LB, Blagg BS. Synthesis and evaluation of electron-rich curcumin analogues. Bioorganic & Medicinal Chemistry. 17: 360-7. PMID 19019687 DOI: 10.1016/J.Bmc.2008.10.057 |
0.558 |
|
Show low-probability matches. |